Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Plenaxis
2. Ppi-149
1. Plenaxis
2. 183552-38-7
3. Ppi-149
4. Ppi 149
5. R 3827
6. R3827
7. R-3827
8. Chembl1252
9. Plenaxis Depot
10. Chebi:337298
11. D-alaninamide, N-acetyl-3-(2-naphthalenyl)-d-alanyl-4-chloro-d-phenylalanyl-3-(3-pyridinyl)-d-alanyl-l-seryl-n-methyl-l-tyrosyl-d-asparaginyl-l-leucyl-n6-(1-methylethyl)-l-lysyl-l-prolyl-
12. Abarelix-depot-m
13. Plenaxis (tn)
14. Abarelix (usan/inn)
15. Abarelix [usan:inn]
16. Unii-w486sj5824
17. N-acetyl-3-(2-naphthyl)-d-alanyl-4-chloro-d-phenylalanyl-3-(3-pyridyl)-d-alanyl-l-seryl-n-methyl-l-tyrosyl-d-asparginyl-l-leucyl-n6-isopropyl-l-lysyl-l-prolyl-d-alaninamide
18. Schembl9533
19. Gtpl1188
20. Ppi149
21. Schembl19712245
22. Dtxsid20171443
23. Bdbm50102442
24. Ppi 149r3827
25. R3827;ppi 149
26. Cs-5873
27. Db00106
28. D-alaninamide, N-acetyl-3-(2-naphthalenyl)-d-alanyl-4-chloro-d-phenylalanyl-3-(3-pyridinyl)-d-alanyl-l-seryl-n-methyl-l-tyrosyl-d-asparaginyl-l-leucyl-n6-(1-methylethyl)-l-lysyl-l-prolyl- 10
29. Hy-13534
30. N-acetyl-3-(2-naphthyl)-d-alanyl-4-chloro-d-phenylalanyl-3-(pyridin-3-yl)-d-alanyl-l-seryl-n-methyl-l-tyrosyl-d-asparginyl-l-leucyl-n(6)-isopropyl-l-lysyl-l-prolyl-d-alaninamide
31. A12613
32. D02738
33. 552a387
34. Q305555
35. Ac-d-nal-[d-(pcl)phe]-d-pal-ser-[nalpha-me-tyr]-d-asn-leu-ilys-pro-dala-nh2
36. N-acetyl-3-(2-naphthyl)-d-alanyl-4-chloro-d-phenylalanyl-3-(3-pyridyl)-d-alanyl-l-seryl-n-methyl-l-tyrosyl-d-asparagyl-l-leucyl-n6-isopropyl-l-lysyl-l-prolyl-d-alaninamide
Molecular Weight | 1416.1 g/mol |
---|---|
Molecular Formula | C72H95ClN14O14 |
XLogP3 | 3.7 |
Hydrogen Bond Donor Count | 13 |
Hydrogen Bond Acceptor Count | 16 |
Rotatable Bond Count | 38 |
Exact Mass | 1414.6840715 g/mol |
Monoisotopic Mass | 1414.6840715 g/mol |
Topological Polar Surface Area | 425 Ų |
Heavy Atom Count | 101 |
Formal Charge | 0 |
Complexity | 2770 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
For palliative treatment of advanced prostate cancer.
FDA Label
Used in the palliative treatment of advanced prostate cancer. Abarelix is a luteinizing hormone agonist that results in suppression of testicular or follicular steroidogenesis.
Hormone Antagonists
Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. (See all compounds classified as Hormone Antagonists.)
L - Antineoplastic and immunomodulating agents
L02 - Endocrine therapy
L02B - Hormone antagonists and related agents
L02BX - Other hormone antagonists and related agents
L02BX01 - Abarelix
Absorption
Following IM administration of 100 mg, abarelix is absorbed slowly with a mean peak concentration of 43.4 ng/mL observed approximately 3 days after the injection.
In vitro hepatocyte (rat, monkey, human) studies and in vivo studies in rats and monkeys showed that the major metabolites of abarelix were formed via hydrolysis of peptide bonds. No significant oxidative or conjugated metabolites of abarelix were found either in vitro or in vivo. There is no evidence of cytochrome P-450 involvement in the metabolism of abarelix.
13.2 ± 3.2 days
Abarelix binds to the gonadotropin releasing hormone receptor and acts as a potent inhibitor of gonadotropin secretion.
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
68
PharmaCompass offers a list of Abarelix API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Abarelix manufacturer or Abarelix supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Abarelix manufacturer or Abarelix supplier.
PharmaCompass also assists you with knowing the Abarelix API Price utilized in the formulation of products. Abarelix API Price is not always fixed or binding as the Abarelix Price is obtained through a variety of data sources. The Abarelix Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Abarelix manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Abarelix, including repackagers and relabelers. The FDA regulates Abarelix manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Abarelix API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Abarelix manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Abarelix supplier is an individual or a company that provides Abarelix active pharmaceutical ingredient (API) or Abarelix finished formulations upon request. The Abarelix suppliers may include Abarelix API manufacturers, exporters, distributors and traders.
click here to find a list of Abarelix suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Abarelix Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Abarelix GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Abarelix GMP manufacturer or Abarelix GMP API supplier for your needs.
A Abarelix CoA (Certificate of Analysis) is a formal document that attests to Abarelix's compliance with Abarelix specifications and serves as a tool for batch-level quality control.
Abarelix CoA mostly includes findings from lab analyses of a specific batch. For each Abarelix CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Abarelix may be tested according to a variety of international standards, such as European Pharmacopoeia (Abarelix EP), Abarelix JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Abarelix USP).